Author

Aya Matsui

Harvard UniversityORCID 0000-0002-9454-7829Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Assay:imaging· 1

Frequent Co-Authors

Akiteru GotoiD· 1 shared Alexei HernandeziD· 1 shared Atsuyo MoritaiD· 1 shared Daichi MaedaiD· 1 shared Dan Gabriel DudaiD· 1 shared Erin M. CoyneiD· 1 shared Grace Caroline BirchiD· 1 shared Hirofumi TakemuraiD· 1 shared

Activity by Year

2023-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

Akiteru GotoORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

PathologybioRxivPreprintSep 10, 2025

Pathological Angiogenesis Precedes the Onset of Aortic Dissection

Kazuaki Yoshioka, Kenji Iino, Yukinobu Ito…·Hisamichi Naito

This study identifies pathological angiogenesis as a key driver of non-heritable aortic dissection, revealing its role in disease onset and potential therapeutic targets.

DOI 10.1101/2025.09.10.675317

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintOct 20, 2023

Liver fibrosis uncouples tumor control from survival after multikinase inhibitor immunotherapy in hepatocellular carcinoma

Satoru Morita, Tomofumi Ando, Hiroto Kikuchi…·Dan Gabriel Duda

Liver fibrosis limits the survival benefit of multikinase inhibitor immunotherapy in hepatocellular carcinoma by promoting innate immune-mediated hepatotoxicity despite preserved tumor control.

3 citations

mousehuman

𝕏 PostBluesky